You can now apply to the newly re-launched version of the NWL Fellowship Programme.
The Fellowship is a year long programme available to all clinicians at any stage of their career, who are in salaried roles (minimum 16 hours).
National flu immunisation programme 2024 to 2025 letter
This letter sets out guidance for the 2024 to 2025 season and includes the next steps for regions and providers to take, including which flu vaccines to order.
Access the flyer with booking links here.
Immunisation patient group direction (PGD) templates
PGD templates to support national immunisation programmes provided on the NHS are now available.
The UKHSA primary care immunisation update webinar dates for September 2024 – January 2025 are now available.
Immunisers in primary care in London can access free immunisation update training across 2024. The series of webinars are designed to support immunisers to fulfil the requirement for annual immunisation updates and are free to access.
Access the flyer with booking links here.
For those General Practice Nurses unable to attend the RSV webinars, the links to both webinars are linked below, with resources and slide decks. For any additional information or enquiries, please use contact the emails below in bold.
Recording links
The recording link for both webinars, on the maternal programme (9th July) and the older person programme (12th July), can be accessed below:
- Recording link for older person RSV vaccine programme webinar
- Recording link for maternal RSV vaccine programme webinar
- Google Drive link – RSV webinars
Slides
The slides can be accessed below:
- Slides for older person RSV vaccine programme webinar
- Slides for maternal RSV vaccine programme webinar
Vaccine preparation video
The manufacturer (Pfizer) video of how to prepare the ABRYSVO RSV Vaccine is below (the same video was shown in both webinars): Pfizer preparation video
Further resources
The RSV vaccination programme documents can be accessed on GOV.UK at the link below. This includes recent updates on the Green Book and training slide sets and guidance for healthcare professionals. This will be updated with further resources in the coming weeks ahead of the operational rollout from September 2024.
- RSV vaccination programme: document collection
- UKHSA immunisation training resources can be found at Immunisation training resources
- Link to Health Publications web page: Health Publications website
For any logistical questions about the webinars, please email externalaffairs@ukhsa.gov.uk
For clinical queries or queries about supporting programme resources, please email immunisation@ukhsa.gov.uk
If your Practice has recently recruited a RGN nurse that is new to Primary Care, then your supportive Training Hub is offering to help!
Central London Training Hub will FUND the training of any Registered Nurses NEW to Primary Care.
For more information, contact clh.traininghub@nhs.net
About this Event
This course covers the fundamental theoretical and practical principles associated with being a Healthcare Assistant (HCA). The course also covers all the Care Certificate Standards.
Course Aims
– Explore and understand the role of the health care assistant
– Understand the importance of safe clinical practice
– Comprehensively cover the fundamental skills applicable to health care assistants
Please contact the training hub for training dates.
CLOCS-2 is an observational, retrospective case-control study that investigates whether or not everyday loyalty card use in high street retailers can help identify early signs of cancer. The cancer types in focus are bladder, bowel (also known as colon/colorectal), endometrial, liver, oesophageal, ovarian, pancreatic, stomach, uterine and vulval. CLOCS-2 is using a case-control design to compare purchasing patterns of participants with (cases) and without (controls) these cancer types diagnose in order to potentially develop a way to detect cancer earlier. The study aims to include participants with and without cancer across the United Kingdom who use loyalty cards at two high street retailers. The CLOCS team will analyse past purchasing behaviour from about 1,500 participants (750 cancer cases and 750 controls) in the United Kingdom utilising information already collected through their use of loyalty cards.
Faecal calprotectin (FC) serves as a calcium-binding cytosolic protein secreted by neutrophils, finding wide application as a screening tool for gastrointestinal inflammation. Numerous studies have highlighted elevated FC levels in patients with inflammatory bowel disease (IBD) compared to control groups like those with irritable bowel syndrome (IBS). Its utility extends to IBD management due to its correlation with disease activity markers. The cost-effectiveness of FC testing and its potential to reduce unnecessary referrals to secondary care have resulted in its widespread adoption in primary care settings. As a stable protein constituting a significant portion of neutrophil cytosolic content, calprotectin is released into feces during gastrointestinal inflammation, offering a non-invasive, cost-effective, and objective means of assessing patients before considering more invasive procedures such as colonoscopy or imaging studies. A prospective study will be conducted to assess the utility of faecal calprotectin (FC) testing in primary care settings, focusing on patients referred for this test. Baseline clinical information will be collected from recruited patients, and the Bristol Stool Scale score will be noted on the faecal samples sent for FC testing to gauge stool consistency. Participants will be followed up over a one-year period to track the outcomes of subsequent investigations, aiding in the determination of appropriate FC cut-off values and evaluating the impact of stool consistency on FC diagnostic efficacy. This research aims to address existing concerns regarding FC testing, particularly its application in primary care and the need for clearer cut-off values. By prospectively investigating FC utility and re-evaluating its cut-off value, this study seeks to enhance diagnostic accuracy in distinguishing between inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) and streamline referral pathways for patients presenting with gastrointestinal symptoms.
For more information click here
Social isolation and loneliness (SI&L) have profound implications for public health, affecting both physical and mental well-being. With a focus on addressing the escalating incidence of SI&L, particularly in London’s Hammersmith & Fulham borough (LBH&F), our research seeks to assess its prevalence across England using online tools. Targeting vulnerable populations, including those with limited cognitive capacity, developmental disorders, dementia, and serious mental illnesses, we aim to identify effective interventions. Through dissemination in peer-reviewed journals, our findings aim to inform policies and practices to combat SI&L. Collaboratively led by Imperial College London’s School of Public Health, Imperial College Healthcare NHS Trust, and Hammersmith & Fulham Council, the Measuring Loneliness (INTERACT) study represents a pioneering effort to map loneliness at the borough and city levels. By engaging thousands of community dwellers aged 16 and over through online surveys, this study aims to provide a comprehensive understanding of loneliness’s impact across various regions, supported by funding from NIHR Applied Research Collaboration NWL.
To find out more click here
